| |
eGFR
|
Framingham
|
|---|
|
ASVD hospitalizations (n = 307)
| | |
|
MDRD
|
1.33 (1.15-1.53)
|
1.48 (1.29-1.69)
|
|
CKD-EPI
|
1.31 (1.15-1.50)
|
1.47 (1.28-1.68)
|
|
ASVD deaths (n = 129)
| | |
|
MDRD
|
1.29 (1.05-1.57)
|
1.37 (1.14-1.64)
|
|
CKD-EPI
|
1.32 (1.09-1.59)
|
1.36 (1.13-1.63)
|
|
ASVD events (n = 369)
| | |
|
MDRD
|
1.31 (1.14-1.50)
|
1.43 (1.26-1.63)
|
|
CKD-EPI
|
1.30 (1.15-1.48)
|
1.43 (1.25-1.62)
|
- The results are odds ratio and 95% confidence interval per SD decrease in eGFR and per SD increase in Framingham risk score includes age, body mass index, smoking, systolic blood pressure and diabetes. ASVD atherosclerotic vascular disease, eGFR estimated glomerular filtration rate, MDRD Modification of Diet in Renal Disease equation, CKD-EPI Chronic Kidney Disease EPIdemiology equation.
